Physician profile
Elyse Ellen Lower
NPI 1447244843
$312,378.45
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89K · 2020: $51K · 2021: $50K · 2022: $98K · 2023: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Travel and Lodging: $3,661 · Consulting Fee: $1,370 · Food and Beverage: $542.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,900.00 |
| Travel and Lodging | $3,661.27 |
| Consulting Fee | $1,370.00 |
| Food and Beverage | $541.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $87,281.98 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $60,298.39 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $55,106.90 | 2019-2020 | |
| Seagen INC. | $49,278.36 | 2022-2023 | Tukysa |
| Daiichi Sankyo INC. | $32,067.26 | 2020-2023 | Enhertu |
| Puma Biotechnology, INC. | $14,697.29 | 2019-2021 | |
| Immunomedics, INC. | $5,359.70 | 2020 | |
| Gen-Probe Sales & Service, INC. | $4,152.29 | 2022 | |
| Eisai INC. | $1,745.00 | 2019 | |
| Hologic Sales and Service, LLC | $1,212.70 | 2023 | Btx, Fetal Fibronectin Enzyme Immunoassay, Aptima |
| Mallinckrodt Hospital Products INC. | $1,148.21 | 2020-2022 | |
| United Therapeutics Corporation | $30.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elyse Lower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.